Stockreport

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND [Yahoo! Finance]

VIRPAX PHARMS INC  (VRPX) 
PDF developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today a [Read more]